I agree that this site is using cookies. You can find further informations here.
X
Venugopal, Sangeetha
90  results:
Search for persons X
?
1

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology.  11 (2024)  3 - p. e186-e195 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia.  1 (2024)  2 - p. 100016 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Targeted therapy with the mutant IDH2 inhibitor enasidenib ..:

DiNardo, Courtney D. ; Venugopal, Sangeetha ; Lachowiez, Curtis...
Blood Advances.  7 (2023)  11 - p. 2378-2387 , 2023
Link: https://doi.org/10.1182/..
 
?
4

S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN CO..:

Bataller, Alex ; Bazinet, Alexandre ; Venugopal, Sangeetha...
HemaSphere.  7 (2023)  S3 - p. e18588ff , 2023
Link: https://doi.org/10.1097/..
 
?
5

P723: CLINICAL AND MOLECULAR ASSOCIATIONS WITH OUTCOMES IN ..:

Bazinet, Alexandre ; Prasad Desikan, Sai ; LI, Ziyi...
HemaSphere.  7 (2023)  S3 - p. e554617b , 2023
Link: https://doi.org/10.1097/..
 
?
6

Clinical outcomes associated with NPM1 mutations in patient..:

Issa, Ghayas C. ; Bidikian, Aram ; Venugopal, Sangeetha...
Blood Advances.  7 (2023)  6 - p. 933-942 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Olutasidenib: from bench to bedside:

Venugopal, Sangeetha ; Watts, Justin
Blood Advances.  7 (2023)  16 - p. 4358-4365 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Trying to outRun‐DIC in KMT2Ar AML: It's tricky:

Venugopal, Sangeetha ; Taylor, Justin
Cancer.  129 (2023)  12 - p. 1797-1799 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Impact of frontline treatment approach on outcomes in patie..:

Short, Nicholas J. ; Venugopal, Sangeetha ; Qiao, Wei...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
10

Poster: MDS-520 A Phase I/II Study of Venetoclax in Combina..:

Venugopal, Sangeetha ; Kantarjian, Hagop ; Maiti, Abhishek...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S150 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Efficacy and safety of enasidenib and azacitidine combinati..:

Venugopal, Sangeetha ; Takahashi, Koichi ; Daver, Naval...
Blood Cancer Journal.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
12

Validation of ALFA 1200 score in patients with AML >60 year..:

Venugopal, Sangeetha ; Borthakur, Gautam ; Daver, Naval...
Blood Advances.  6 (2022)  19 - p. 5546-5549 , 2022
Link: https://doi.org/10.1182/..
 
?
13

Differential prognostic impact of RUNX1 mutations according..:

Venugopal, Sangeetha ; DiNardo, Courtney D. ; Loghavi, Sanam...
American Journal of Hematology.  97 (2022)  12 - p. 1560-1567 , 2022
Link: https://doi.org/10.1002/..
 
?
14

The odyssey of pacritinib in myelofibrosis:

Venugopal, Sangeetha ; Mascarenhas, John
Blood Advances.  6 (2022)  16 - p. 4905-4913 , 2022
Link: https://doi.org/10.1182/..
 
?
15

MDS-520 A Phase I/II Study of Venetoclax in Combination Wit..:

Venugopal, Sangeetha ; Kantarjian, Hagop ; Maiti, Abhishek...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S321 , 2022
Link: https://doi.org/10.1016/..
 
1-15